MARNEFFE, Wim

Email Alert RSS Feed

Profile

Full Name
MARNEFFE, Wim
Email
wim.marneffe@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Author:  MARNEFFE, Wim

Results 101-120 of 144 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
1012015Who is to blame for court delay in Belgium. Empirical analysis of construction and contract casesBIELEN, Samantha; MARNEFFE, WimConference MaterialC2
1022015Medical professional liability in Belgium: a claim duration analysisVANDERSTEEGEN, Tom; MARNEFFE, WimConference MaterialC2
1032015The Cost Savings, Enablers and Barriers of Electronic Invoicing in BelgiumPOEL, Kevin; MARNEFFE, Wim; VANLAER, WillemConference MaterialC2
1042015The Cost Savings, Enablers and Barriers of Electronic Invoicing in BelgiumPOEL, Kevin; MARNEFFE, WimConference MaterialC2
1052015The Cost Savings, Enablers and Barriers of Electronic Invoicing in BelgiumPOEL, Kevin; MARNEFFE, WimConference MaterialC2
1062015Institutions, Misdemeanors and Fraud in EuropeMOCAN, Naci; Pogorelova, Luiza; BIELEN, Samantha; MARNEFFE, WimConference MaterialC2
1072015Identifying the determinants of crime in Flemish municipalities: a spatial analysisINDESTEEGE, Jana; MARNEFFE, Wim; BIELEN, SamanthaConference MaterialC2
1082015Forum shopping and the congestion equilibrium theory. An analysis of the litigation of construction disputes in Belgian courtsBIELEN, Samantha; MARNEFFE, WimConference MaterialC2
1092014Administrative Simplification and Economic Growth: A Cross Country Empirical StudyPOEL, Kevin; MARNEFFE, Wim; BIELEN, Samantha; VAN AARLE, Bas; VEREECK, LodeJournal ContributionA2
1102014De federale regelgevingsimpactanalyse: een stand van zaken na zes maanden.POEL, Kevin; MARNEFFE, WimJournal ContributionA1
1112014De invloed van de toegang tot justitie op de instroom van rechtszaken: een empirische analyseBIELEN, Samantha; MARNEFFE, Wim; POPELIER, PatriciaJournal ContributionA1
1122014Cost-effectiveness of gemcitabine versus PEGylated liposomal doxorubicin for recurrent or progressive ovarian cancer: comparing chemotherapy with nanotherapyBOSETTI, Rita; Ferrandina, Gabriella; MARNEFFE, Wim; Scambia, Giovanni; VEREECK, LodeJournal ContributionA1
1132014A cross-country analysis of the impact of regulatory quality on commercial case disposition timeBIELEN, Samantha; MARNEFFE, Wim; VEREECK, LodeJournal ContributionA1
1142014Elektronische facturatie in België: een kans of bedreiging volgens de cijferberoepenPOEL, Kevin; MARNEFFE, Wim; Steyaert, JoJournal ContributionA1
1152014De reguleringsimpactanalyse en de bescherming van grondrechten: een verantwoordelijkheid van wetgever en rechter. Een toepassing op het huisonderwijs.MARNEFFE, Wim; Popelier, PatriciaJournal ContributionA1
1162014Does Compliance to Patient Safety Tasks Improve and Sustain when Radiotherapy Treatment Processes are Standardized?SIMONS, Pascale; Houben, Ruud; Benders, Jos; Pijls-Johannesma, Madelon; VANDIJCK, Dominique; MARNEFFE, Wim; Backes, Huub; Groothuis, SiebrenJournal ContributionA1
1172014Administrative burdens and economic growth in EuropeMARNEFFE, Wim; POEL, Kevin; BIELEN, Samantha; VEREECK, LodeConference MaterialC2
1182014Explaining the demand for court servicesBIELEN, Samantha; MARNEFFE, WimConference MaterialC2
1192014Physician specialists’ perceptions of the medical malpractice reform in BelgiumVANDERSTEEGEN, Tom; MARNEFFE, Wim; DE GENDT, Tom; CLEEMPUT, Irina; VANDIJCK, Dominique; VEREECK, LodeConference MaterialC2
1202014A cross-country analysis of the impact of regulatory quality on commercial case disposition time.MARNEFFE, Wim; BIELEN, Samantha; VEREECK, LodeConference MaterialC2
show all